AMSilk appoints Gudrun Vogtentanz as Chief Scientific Officer
Munich, 17 October, 2023: AMSilk GmbH (“AMSilk”), the world’s first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO). Gudrun will be responsible for AMSilk’s protein and strain strategy as well as bridging science and business development.
With many years of experience in biotechnology research, Gudrun has a proven international track record in project and portfolio management, as well as R&D product development. She joins from DSM Nutritional Products in Switzerland, where she was Innovation Program Director, establishing new portfolio processes and leading strategic innovation projects. Prior to that, she was Research Program Director at Biomin Holding, where she oversaw the enzyme portfolio for animal nutrition and health. Gudrun also spent over 15 years working in the US as a scientist at DuPont Industrial Biosciences, based in Palo Alto, CA, where she established protein engineering processes shortening time-to-market and led cross-functional teams.
